UB-221
Based on 1 Customer Validation
UB-221 is an anti-IgE monoclonal antibody (human IgE Kd = 5.85×10-11 M). UB-221 blocks the IgE-FcεRI interaction and promotes CD23 binding by binding to free IgE and CD23-bound IgE, inhibits basophil activation and degranulation, stabilizes membrane-bound CD23 on B lymphocytes and downregulates IgE synthesis, and induces apoptosis (Apoptosis) of B cells expressing membrane-bound IgE. UB-221 directs IgE toward non-inflammatory clearance pathways, reduces IgE levels and FcεRI expression, and can be used for research on chronic spontaneous urticaria and food allergy.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 98.95%
- CAS. Nr.: 2755114-30-6
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
Species Reactivity
Human
IC50 & Target
IGHE
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Ramos | EC50 |
7.9 ng/mL
|
Binding to Ramos B cells expressing long-form membrane-bound IgE measured as mean EC50.
Binding to Ramos B cells expressing long-form membrane-bound IgE measured as mean EC50.
|
35912861 |
In Vitro
UB-221 does not trigger ADCC/CDC in IgE-preloaded CD23-overexpressing SKW6.4 cells and does not induce cytokine release from human PBMCs[1].
UB-221 binds IgE that is bound to CD23, and the preformed UB-221-IgE complex binds CD23 in ELISA, with EC50 values of 39.1 and 41.6 ng/mL, respectively[1].
UB-221 blocks FcεRI-mediated RBL SX-38 degranulation with an IC50 of 0.14 μg/mL and does not activate human basophils[1].
UB-221 (0-75,000 ng/mL; 1 hour at room temperature) neutralizes high IgE in human serum samples, with an EC90 of 1,097 ng/mL in the low IgE group and 27,539 ng/mL in the high IgE group[1].
UB-221 inhibits FcεRI interaction and promotes CD23 binding in in vitro IgE receptor interaction assays[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Parmacokinetics
| Species | Dose | Route | T1/2 |
|---|---|---|---|
| Cynomolgus Monkey[1] | 5.0 mg/kg | i.v. | 6.3 day |
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Cynomolgus macaque (cynomolgus monkey; n=3; suitable pharmacology and toxicology animal model)[1]
-
Dosage:5.0 mg/kg
-
Administration:i.v.; single dose
-
Result:Induced a rapid, pronounced reduction in serum free cIgE by 90% to 100%.
-
Animal Model:hIGHE-knockin (human IgE ε,κ-knockin; F1 hybrid of male C57BL/6 background crossed with female BALB/c; 8-16 weeks old)[1]
-
Dosage:0.3 mg/kg or 3.0 mg/kg
-
Administration:i.p.; single dose
-
Result:Rapidly reduced high serum free-chimeric-IgE levels by greater than 90%.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Anwendung
ELISA, FACS, Functional assay
Chemical Information
-
CAS. Nr. 2755114-30-6
-
Appearance Liquid
-
Color Colorless to light yellow
-
SMILES
N/A
-
Versand
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
-
Data Sheet (274 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)